Skip to main content
Sri Yarlagadda, MD, Nephrology, Kansas City, KS, The University of Kansas Hospital

SriGYarlagaddaMD

Nephrology Kansas City, KS

Associate Professor, Internal Medicine, University of Kansas School of Medicine

Dr. Yarlagadda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yarlagadda's full profile

Already have an account?

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Nephrology, 2005 - 2008
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 2002 - 2004
  • St Barnabas Hospital
    St Barnabas HospitalInternship, Internal Medicine, 2001 - 2002
  • M. Rampure Medical College
    M. Rampure Medical CollegeClass of 2000

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2021 - 2025
  • KS State Medical License
    KS State Medical License 2008 - 2024
  • CT State Medical License
    CT State Medical License 2007 - 2008
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Young Investigator Award American Society of Hypertension-Eastern Chapter, 2004
  • Certificate of Merit in Medicine 1998
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Metastatic Calcifications after parathyroidectomy in a dialysis patient  
    Munis Mattu and Sri G Yarlagadda, Nephrology, 1/1/2013
  • First Case of Donor Transmitted Non Leukemic Promyelocytic Sarcoma  
    Williams T, Aljitawi OS, Moussa R, McHugh S, Dusing R, Abraha J, Yarlagadda SG, Leuk Lymphoma, 1/9/2012
  • Blood group A isoagglutinins in A2-> O simultaneous liver/kidney transplantation may not influence kidney function  
    Bryan CF, Abdulkarim A, Nawabi A, Stewart A, and Yarlagadda SG, American Journal of Transplantation, 1/1/2011
  • Join now to see all

Abstracts/Posters

  • The influence of HLA Class 2 donor specific antibodies present at the time of renal transplantation on Early Graft Outcome
    Christopher Bryan, Aditi Gupta, Daniel Murillo, Connie Wang, Sri G Yarlagadda, Atta Nanwabi, Timothy Schmitt, American Transplant Congress, 1/1/2013
  • Urinary Cystatin C and KIM-1: A Tale of Two Novel Biomarkers of Acute Kidney Injury in Predicting the Need for Dialysis after Kidney Transplantation
    Sri G. Yarlagadda, American Transplant Congress Meeting, 1/1/2009
  • Urine NGAL and IL-18 are better markers of DGF compared to existing parameters.
    Sri G. Yarlagadda, American Society of Nephrology Meeting, 1/7/2008
  • Join now to see all

Other

  • Effect of diuretics on magnesium handling by the kidney. 
    Alan S L Yu, Sri G Yarlagadda, UpToDate
    1/1/2013
  • Clinical Manifestations of magnesium depletion. 
    Alan S L Yu, Sri G Yarlagadda, UpToDate
    1/1/2013
  • Parathyroid and Mineral Metabolism after renal transplantation. 
    Sri G Yarlagadda, David W Butterly, L Darryl Quarles, UpToDate
    1/1/2009

Hospital Affiliations